The epidemiology of chlamydia trachomatis organism load during genital infection: A systematic review

Journal of Infectious Diseases

Volumn 211, Issue 10, 2015, Pages 1628-1645

  Vodstrcil, Lenka A ^a,b,c   McIver, Ruthy ^d   Huston, Wilhelmina M ^e   Tabrizi, Sepehr N ^c,f   Timms, Peter ^e,g   Hocking, Jane S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

Chlamydia trachomatis; Culture; Nucleic acid amplification; Organism load; Systematic review

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BACTERIAL LOAD; BACTERIAL TRANSMISSION; CHLAMYDIASIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENITAL SYSTEM EXAMINATION; GENITAL TRACT INFECTION; HORMONE BLOOD LEVEL; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; RECTAL SWAB; SEROTYPE; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; URETHRAL SWAB; URINE CULTURE; UTERINE CERVIX; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PATHOLOGY; REPRODUCTIVE TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX;

BACTERIAL LOAD; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MALE; REPRODUCTIVE TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 84929660048     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu670     Document Type: Article

References (50)

1. World Health Organization (WHO). Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: WHO, 2012.
2. Peipert JF. Genital chlamydial infections. New Eng J Med 2003; 349: 2424-30.
3. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201(suppl 2):S134-55.
4. Trojian TH, Lishnak TS, Heiman D. Epididymitis and orchitis: An overview. Am Fam Physician 2009; 79:583-7.
5. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Inf 1999; 75:3-17.
6. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008; 35:53-4.
7. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-404.
8. Hocking JS, Guy R, Walker J, Tabrizi SN. Advances in sampling and screening for chlamydia. Future Microbiol 2013; 8:367-86.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Medicine 2007; 4:e296.
11. Forcey DS, Hocking JS, Tabrizi SN, et al. Chlamydia detection during the menstrual cycle: A cross-sectional study of women attending a sexual health service. PLoS One 2014; 9:e85263.
12. Dukers-Muijrers NH, Speksnijder AG, Morre SA, et al. Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. PLoS One 2013; 8:e81236.
13. Walker J, Fairley C, Bradshaw CS, et al. Chlamydia trachomatis incidence and re-infection among young women-behavioural and microbiological characteristics. PLoS One 2012; 7:e37778.
14. Walker J, Fairley CK, Bradshaw CS, et al. The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 2011; 11:35.
15. Jalal H, Verlander NQ, Kumar N, Bentley N, Carne C, Sonnex C. Genital chlamydial infection: Association between clinical features, organism genotype and load. J Med Microbiol 2011; 60:881-8.
16. Twin J, Moore EE, Garland SM, et al. Chlamydia trachomatis genotypes among men who have sex with men in Australia. Sex Transm Dis 2011; 38:279-85.
17. Van Der Pol B, Pantone A,Williams J. Using organism load of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical specimens as an epidemiologic tool [poster P1-S4.03]. Sex Transm Infect 2011; 87:A161.
18. Wiggins R, Graf S, Low N, Horner PJ. Real-time quantitative PCR to determine chlamydial load in men and women in a community setting. J Clin Microbiol 2009; 47:1824-9.
19. Baczynska A, Hvid M, Lamy P, Birkelund S, Christiansen G, Fedder J. Prevalence of Mycoplasma genitalium, Mycoplasma hominis and Chlamydia trachomatis among Danish patients requesting abortion. Sys Biol Reprod Med 2008; 54:127-34.
20. Michel C-EC, Sonnex C, Carne CA, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007; 45:1395-402.
21. Gomes JP, Borrego MJ, Atik B, et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect 2006; 8:16-26.
22. Agrawal T, Vats V, Wallace PK, Singh A, Salhan S, Mittal A. Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection. Clin Micro Infect 2009; 15:50-9.
23. Agrawal T, Vats V, Salhan S, Mittal A. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immun Med Micro 2009; 55:250-7.
24. Geisler WM, Whittington WLH, Suchland RJ, Stamm WE. Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: utilizing serovar and auxotype strain typing. Sex Transm Dis 2002; 29:189-95.
25. Geisler WM, Suchland RJ, Whittington WL, Stamm WE. Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J Infect Dis 2001; 184:1350-4.
26. Eckert LO, Suchland RJ, Hawes SE, Stamm WE. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J Infect Dis 2000; 182:540-4.
27. Boisvert JF, Koutsky LA, Suchland RJ, Stamm WE. Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex Transm Dis 1999; 26:392-8.
28. Workowski K, Stevens C, Suchland R, et al. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis 1994; 19:756-60.
29. Frost EH, Deslandes S, Bourgaux-Ramoisy D. Chlamydia trachomatis serovars in 435 urogenital specimens typed by restriction endonuclease analysis of amplified DNA. J Infect Dis 1993; 168:497-501.
30. Workowski KA, Suchland RJ, Pettinger MB, Stamm WE. Association of genital infection with specific Chlamydia trachomatis serovars and race. J Infect Dis 1992; 166:1445-9.
31. Barnes RC, Katz BP, Rolfs RT, Batteiger B, Caine V, Jones RB. Quantitative culture of endocervical Chlamydia trachomatis. J Clin Microbiol 1990; 28:774-80.
32. Singal SS, Reichman RC, Graman PS, Greisberger C, Trupei MA, Menegus MA. Isolation of Chlamydia trachomatis from men with urethritis: relative value of one vs. Two swabs and influence of concomitant gonococcal infection. Sex Transm Dis 1986; 13:50-2.
33. Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-4.
34. Mallinson H, Arya OP, Goddard AD. Quantitative study of Chlamydia trachomatis in genital infection. Br J Ven Dis 1982; 58:36-9.
35. Hobson D, Karayiannis P, Byng RE, Rees E, Tait IA, Davies JA. Quantitative aspects of chlamydial infection of the cervix. Br J Ven Dis 1980; 56:156-62.
36. Tait IA, Rees E, Hobson D, Byng RE, Tweedie MC. Chlamydial infection of the cervix in contacts of men with nongonococcal urethritis. Br J Ven Dis 1980; 56:37-45.
37. Hilton AL, Richmond SJ, Milne JD, Hindley F, Clarke SK. Chlamydia A in the female genital tract. The Br J Ven Dis 1974; 50:1-10.
38. Thomas BJ, Pierpoint T, Taylor-Robinson D, Renton AM. Quantification of Chlamydia trachomatis in cervical and urine specimens from women attending a genitourinary medicine clinic: implications for screening strategies. Int J STD AIDS 1998; 9:448-51.
39. Thomas BJ, Osborn MF, Munday PE, Evans RT, Taylor-Robinson D. A 2-year quantitative assessment of Chlamydia trachomatis in a sexually transmitted diseases clinic population by the MicroTrak direct smear immunofluorescence test. Int J STD AIDS 1990; 1:264-7.
40. Bissessor M, Tabrizi S, Fairley C, et al. Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission, and control. J Clin Microbiol 2011; 49:4304-6.
41. van Dommelen L, Wolffs PFG, van Tiel FH, et al. Influence of temperature, medium, and storage duration on Chlamydia trachomatis DNA detection by PCR. J Clin Micro 2013; 51:990-2.
42. Batteiger B, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010; 201:S178-89.
43. Maxion HK, LiuW, Chang M-H, Kelly KA. The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun 2004; 72:6330-40.
44. Carey AJ, Cunningham KA, Hafner LM, Timms P, Beagley KW. Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice. Immunol Cell Biol 2009; 87:337-43.
45. Molano M, Meijer CJLM, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: A 5-year follow-up study. J Infect Dis 2005; 191:907-16.
46. Gray RT, Beagley KW, Timms P, Wilson DP. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis 2009; 199:1680-8.
47. Rours GIJG, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: A population-based prospective cohort study. Eur J Epidemiol 2011; 26:493-502.
48. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011; 108(suppl 1):4680-7.
49. Horner PJ. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Inf 2012; 88:154-6.
50. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study. Lancet 2005; 366: 1296-300. Review